Trial Outcomes & Findings for Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device (NCT NCT00578383)

NCT ID: NCT00578383

Last Updated: 2016-05-16

Results Overview

A multiple choice questionnaire used to rate depression severity. Mean change from pretreatment score. 17 items reflecting depression symptoms are scored on scale of severity; 9 items are scored 0 = Absent 1 = Trivial 2 = Mild 3 = Moderate 4 = Severe 8 items are scored 0 = Absent 1 = Mild 2 = Severe. Items are summed; minimum score is 0, maximum score is 52. Higher scores represent more severe depression.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

107 participants

Primary outcome timeframe

Once just before and once just after treatment

Results posted on

2016-05-16

Participant Flow

Subjects were recruited from March 2008 though February 2011. They were recruited through flyers distributed around McLean Hospital (Belmont, MA), referral by clinic doctors and direct recruitment on the hospital's units.

Enrolled participants are excluded from statistical results if they had baseline Hamilton Depression Rating scores under 17 or co-morbid disorders.

Participant milestones

Participant milestones
Measure
Bipolar Disorder Active LFMS Treatment
Subjects with bipolar depression receiving active treatment with the Low Field Magnetic Stimulation Device.
Bipolar Disorder Sham LFMS Treatment
Subjects with bipolar depression receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Major Depressive Disorder Active LFMS Treatment
Subjects with major depression receiving active treatment with the Low Field Magnetic Stimulation Device.
Major Depressive Disorder Sham LFMS Treatment
Subjects with major depression receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Overall Study
STARTED
37
36
19
15
Overall Study
COMPLETED
21
20
13
9
Overall Study
NOT COMPLETED
16
16
6
6

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Low Field Magnetic Stimulation in Mood Disorders Using the LFMS Device

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Bipolar Disorder Active LFMS Treatment
n=37 Participants
Subjects with bipolar depression receiving active treatment with the Low Field Magnetic Stimulation Device.
Bipolar Disorder Sham LFMS Treatment
n=36 Participants
Subjects with bipolar depression receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Major Depressive Disorder Active LFMS Treatment
n=19 Participants
Subjects with major depression receiving active treatment with the Low Field Magnetic Stimulation Device.
Major Depressive Disorder Sham LFMS Treatment
n=15 Participants
Subjects with major depression receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Total
n=107 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Age, Categorical
Between 18 and 65 years
36 Participants
n=5 Participants
36 Participants
n=7 Participants
19 Participants
n=5 Participants
15 Participants
n=4 Participants
106 Participants
n=21 Participants
Age, Categorical
>=65 years
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
Age, Continuous
42.6 years
STANDARD_DEVIATION 13.0 • n=5 Participants
42.2 years
STANDARD_DEVIATION 12.2 • n=7 Participants
43.1 years
STANDARD_DEVIATION 15.5 • n=5 Participants
43.5 years
STANDARD_DEVIATION 14.9 • n=4 Participants
42.9 years
STANDARD_DEVIATION 13.3 • n=21 Participants
Sex: Female, Male
Female
25 Participants
n=5 Participants
15 Participants
n=7 Participants
12 Participants
n=5 Participants
8 Participants
n=4 Participants
60 Participants
n=21 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
21 Participants
n=7 Participants
7 Participants
n=5 Participants
7 Participants
n=4 Participants
47 Participants
n=21 Participants
Region of Enrollment
United States
37 participants
n=5 Participants
36 participants
n=7 Participants
19 participants
n=5 Participants
15 participants
n=4 Participants
107 participants
n=21 Participants

PRIMARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

A multiple choice questionnaire used to rate depression severity. Mean change from pretreatment score. 17 items reflecting depression symptoms are scored on scale of severity; 9 items are scored 0 = Absent 1 = Trivial 2 = Mild 3 = Moderate 4 = Severe 8 items are scored 0 = Absent 1 = Mild 2 = Severe. Items are summed; minimum score is 0, maximum score is 52. Higher scores represent more severe depression.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=19 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=20 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Mean Change in Hamilton Depression Rating Scale (HAM-D) (17 Item) in Subjects With Bipolar Depression
-8.3 units on a scale
Standard Error 1.0
-5.79 units on a scale
Standard Error 1.07

PRIMARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

A multiple choice questionnaire used to rate depression severity. Mean change from pretreatment score. 17 items reflecting depression symptoms are scored on scale of severity; 9 items are scored 0 = Absent 1 = Trivial 2 = Mild 3 = Moderate 4 = Severe 8 items are scored 0 = Absent 1 = Mild 2 = Severe. Items are summed; minimum score is 0, maximum score is 52. Higher scores represent more severe depression.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=10 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=9 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Mean Change in Hamilton Depression Depression Rating Scale (HAM-D) (17 Item) in Subjects With Major Depressive Disorder
-7.19 units on a scale
Standard Error 1.44
-4.02 units on a scale
Standard Error 1.54

PRIMARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

Eleven point Likert scales indicating immediate depression state. Mean change from pretreatment score. Participant marks an 'X' on a numbered line anchored by 0 = no depression and 10 = most depressed ever been.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=21 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=20 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Visual Analog Scale (VAS) in Subjects With Bipolar Depression
-1.18 units on a scale
Standard Error 0.37
-1.05 units on a scale
Standard Error 0.35

PRIMARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

Eleven point Likert scales indicating immediate depression state. Mean change from pretreatment score. Participant marks an 'X' on a numbered line anchored by 0 = no depression and 10 = most depressed ever been.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=13 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=9 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Visual Analog Scale (VAS) in Subjects With Major Depressive Disorder
-1.33 units on a scale
Standard Error 0.53
0.25 units on a scale
Standard Error 0.25

SECONDARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

A multiple choice questionnaire used to rate depression severity. Mean change from pretreatment score. 17 items reflecting depression symptoms are scored on scale of severity; 9 items are scored 0 = Absent 1 = Trivial 2 = Mild 3 = Moderate 4 = Severe 8 items are scored 0 = Absent 1 = Mild 2 = Severe. Items are summed; minimum score is 0, maximum score is 52. Higher scores represent more severe depression.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=32 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=29 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Mean Change in Hamilton Depression Rating Scale (HAM-D) (17 Item): Combined Diagnostic Groups.
-8.13 units on a scale
Standard Error 0.87
-5.02 units on a scale
Standard Error 0.78

SECONDARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores.

Eleven point Likert scales indicating immediate depression state. Mean change from pretreatment score. Participant marks an 'X' on a numbered line anchored by 0 = no depression and 10 = most depressed ever been.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=34 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=29 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Visual Analog Scale (VAS): Combined Diagnostic Groups.
-1.66 units on a scale
Standard Error 0.29
-0.60 units on a scale
Standard Error 0.23

SECONDARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores.

20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely. Positive and Negative scores are calculated and reported separately and range from 10-50. Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=34 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=29 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Positive and Negative Affect Schedule (PANAS) Positive Score: Combined Diagnostic Group.
3.16 units on a scale
Standard Error 0.93
-0.94 units on a scale
Standard Error 0.79

SECONDARY outcome

Timeframe: once pre and once post LFMS treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores.

20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely. Positive and Negative scores are calculated and reported separately and range from 10-50. Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=34 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=29 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Positive and Negative Affect Schedule (PANAS) Negative Score: Combined Diagnostic Group.
-7.00 units on a scale
Standard Error 1.02
-5.00 units on a scale
Standard Error 0.91

SECONDARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely. Positive and Negative scores are calculated and reported separately and range from 10-50. Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=21 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=20 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Positive and Negative Affect Schedule (PANAS) Positive Score in Subjects With Bipolar Depression.
4.18 units on a scale
Standard Error 1.37
-0.79 units on a scale
Standard Error 0.93

SECONDARY outcome

Timeframe: Once just before and once just after treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely. Positive and Negative scores are calculated and reported separately and range from 10-50. Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=13 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=9 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Positive and Negative Affect Schedule (PANAS) Positive Score in Subjects With Major Depressive Disorder
1.05 units on a scale
Standard Error 1.07
-0.63 units on a scale
Standard Error 1.11

SECONDARY outcome

Timeframe: once pre and once post LFMS treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely. Positive and Negative scores are calculated and reported separately and range from 10-50. Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=21 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=20 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Positive and Negative Affect Schedule (PANAS) Negative Score in Subjects With Bipolar Depression
-7.66 units on a scale
Standard Error 1.45
-6.31 units on a scale
Standard Error 1.39

SECONDARY outcome

Timeframe: once pre and once post LFMS treatment

Population: Qualifying subjects who completed the the study with qualifying HAM-D scores and complete data.

20 item list of words that describe different feelings and emotions with positive and negative valences (10 each), which the subject scores on a 1-5 scale: 1 = very slightly or not at all 2 = a little 3 = moderate 4 = quite a bit 5 = extremely. Positive and Negative scores are calculated and reported separately and range from 10-50. Higher positive score reflects stronger positive affect and higher negative score reflects stronger negative affect.

Outcome measures

Outcome measures
Measure
Combined Group Active LFMS Treatment
n=13 Participants
Combined diagnostic groups receiving active treatment with the Low Field Magnetic Stimulation Device.
Combined Group Sham LFMS Treatment
n=9 Participants
Combined diagnostic groups receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Positive and Negative Affect Schedule (PANAS) Negative Score in Subjects With Major Depressive Disorder
-5.28 units on a scale
Standard Error 1.10
-3.04 units on a scale
Standard Error 0.63

Adverse Events

Bipolar Disorder Active LFMS Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Bipolar Disorder Sham LFMS Treatment

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Major Depressive Disorder Active LFMS Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Major Depressive Disorder Sham LFMS Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Bipolar Disorder Active LFMS Treatment
n=37 participants at risk
Subjects with bipolar depression receiving active treatment with the Low Field Magnetic Stimulation Device.
Bipolar Disorder Sham LFMS Treatment
n=36 participants at risk
Subjects with bipolar depression receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
Major Depressive Disorder Active LFMS Treatment
n=19 participants at risk
Subjects with major depression receiving active treatment with the Low Field Magnetic Stimulation Device.
Major Depressive Disorder Sham LFMS Treatment
n=15 participants at risk
Subjects with major depression receiving sham treatment with the Low Field Magnetic Stimulation Device. The sham treatment is identical to the active treatment, with the exception that subjects to not receive the active stimulation.
General disorders
dizziness at venepuncture
0.00%
0/37 • 2 years, 10 months
participant self report
5.6%
2/36 • Number of events 2 • 2 years, 10 months
participant self report
0.00%
0/19 • 2 years, 10 months
participant self report
0.00%
0/15 • 2 years, 10 months
participant self report

Additional Information

Dr. Michael Rohan

McLean Hospital

Phone: 617-855-3127

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place